
Bangalore Cancer Centre Private Limited
Specialized cancer treatment hospital established in 2009, based in Bangalore, Karnataka.
Specialized cancer treatment hospital established in 2009, based in Bangalore, Karnataka.
Bangalore Cancer Centre Private Limited (BCCPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 July 2009 and has a history of 15 years and seven months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 3.50 Cr.
The company currently has active open charges totaling ₹3.20 Cr. The company has closed loans amounting to ₹5.62 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kandhappan Velavan, Ponmalar, and Rajendran Vijayarani serve as directors at the Company.
Bangaluru, Karnataka, India
+91-XXXXXXXXXX
-
U85100KA2009PTC050359
050359
Private Limited Indian Non-Government Company
10 Jul 2009
30 Sep 2022
31 Mar 2022
Unlisted
Roc Bangalore
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kandhappan Velavan ![]() | Managing Director | 10-Jul-2009 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ponmalar ![]() | Director | 10-Jul-2009 | Current |
Rajendran Vijayarani ![]() | Additional Director | 07-Jul-2011 | Current |
Bangalore Cancer Centre Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 18.7% increase. The company also saw a substantial improvement in profitability, with a 37.93% increase in profit. The company's net worth observed a substantial decline by a decrease of 24.15%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2019, Bangalore Cancer Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Kandhappan Velavan and Ponmalar are mutual person
Kandhappan Velavan and Ponmalar are mutual person
₹3.20 Cr
₹5.62 Cr
Date | Lender | Amount | Status |
---|---|---|---|
17 Aug 2021 | Indian Overseas Bank | ₹2.00 M | Open |
23 Nov 2016 | Others | ₹3.00 Cr | Open |
28 Aug 2020 | Others | ₹1.68 M | Satisfied |
31 Jul 2018 | Others | ₹1.50 Cr | Satisfied |
30 Jun 2015 | City Union Bank Limited | ₹7.00 M | Satisfied |
Unlock and access historical data on people associated with Bangalore Cancer Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Bangalore Cancer Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bangalore Cancer Centre's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 28 Aug 2020 via Charge ID 100375286 with Others was fully satisfied on 21 Mar 2024.
21 Mar 2024
A charge registered on 31 Jul 2018 via Charge ID 100219145 with Others was fully satisfied on 21 Mar 2024.
21 Mar 2024
Bangalore Cancer Centre Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
30 Sep 2022
Bangalore Cancer Centre Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Bangalore.
31 Mar 2022
A charge with Indian Overseas Bank amounted to Rs. 0.20 Cr with Charge ID 100509046 was registered on 17 Aug 2021.
17 Aug 2021
A charge with Others amounted to Rs. 0.17 Cr with Charge ID 100375286 was registered on 28 Aug 2020.
28 Aug 2020
Bangalore Cancer Centre Private Limited was incorporated on 10 Jul 2009.
The authorized share capital of Bangalore Cancer Centre Private Limited is ₹ 3.50 Cr and paid-up capital is ₹ 3.50 Cr.
Currently 3 directors are associated with Bangalore Cancer Centre Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Bangalore Cancer Centre Private Limited is 118/1-2 Mookambika Temple Road Machohalli Gate, Magadi Main Road India, Bangalore, Karnataka, 560091.
The corporate identification number (CIN) of Bangalore Cancer Centre Private Limited is U85100KA2009PTC050359 and the company number is 050359 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2019, the revenue trend for Bangalore Cancer Centre Private Limited has risen by 18.70%.
The financial reports for the fiscal year 2019 indicates that The net worth of Bangalore Cancer Centre Private Limited has experienced an downturn of -24.15%.
As per the financial statements for fiscal Year 2019, The total open charges for Bangalore Cancer Centre Private Limited amount to ₹ 3.20 Cr.
The most recent Balance Sheet for Bangalore Cancer Centre Private Limited was filed with the ROC on 31 Mar 2022.